The advertisement promotes NAYZILAM, a benzodiazepine medication, encouraging viewers to learn about its use for managing seizure clusters and highlighting important safety information.
Creative Information
| CID: | cfc02bef-6d94-4339-b6c6-425f1cdf8ae7 |
| CRID: | 97_8039425 |
| Domain: | nayzilam.com |
| Seat: | Verizon |
| Size: | 300x250 |
| Bid: | $0.35 |
| Timestamp: | 11/17/2025, 5:54:47 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/17/2025, 6:09:14 PM | 7.33s | |
| adomain_analysis | success | 11/17/2025, 7:53:12 PM | 2.86s | |
| adomain_capture | success | 11/17/2025, 7:53:09 PM | 0.08s | |
| ad_render | success | 11/17/2025, 6:09:06 PM | 23.70s | |
| brand_mapping | success | 11/17/2025, 5:54:48 PM | 0.08s | |
Analysis Results
Ad Format: banner
Brands: NAYZILAM
Sensitive:Unverified Medical TreatmentsPharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x250 | ||||||||||||||||||||||
| Data Transferred: | 1271.97 KB | ||||||||||||||||||||||
| Render Time: | 8.27 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1272.09 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


